Correlation Between Pfizer and Icad

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Icad Inc, you can compare the effects of market volatilities on Pfizer and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Icad.

Diversification Opportunities for Pfizer and Icad

0.93
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Pfizer and Icad is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Icad Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icad Inc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icad Inc has no effect on the direction of Pfizer i.e., Pfizer and Icad go up and down completely randomly.

Pair Corralation between Pfizer and Icad

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.18 times more return on investment than Icad. However, Pfizer Inc is 5.64 times less risky than Icad. It trades about -0.1 of its potential returns per unit of risk. Icad Inc is currently generating about -0.09 per unit of risk. If you would invest  4,576  in Pfizer Inc on July 6, 2022 and sell it today you would lose (130.00)  from holding Pfizer Inc or give up 2.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Icad Inc

 Performance (%) 
       Timeline  
Pfizer Inc 
Pfizer Performance
0 of 100
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in November 2022. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pfizer Price Channel

Icad Inc 
Icad Performance
0 of 100
Over the last 90 days Icad Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in November 2022. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Icad Price Channel

Pfizer and Icad Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Icad

The main advantage of trading using opposite Pfizer and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.
Pfizer vs. Amazon Inc
The idea behind Pfizer Inc and Icad Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Icad vs. General Electric
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go